Curriculum vitae

Wissenschaftlicher Werdegang
2023 Nachwuchsgruppenleiterin, Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie - Hans-Knöll-Institut - (Leibniz-HKI), Jena
2022 Postdoc, Nachwuchsgruppe Biobricks Mikrobieller Naturstoffsynthesen (Dr. Vito Valiante), Leibniz-HKI, Jena
2019-2022 Gastwissenschaftlerin (Stipendien der Deutschen Forschungsgemeinschaft und der Stiftung van Wijck-Stam-Caspersfonds), Abt. Molekulare Pflanzenpathologie (Prof. Martijn Rep), Universität Amsterdam, Niederlande
  ‚Die Rolle von Histonmodifikationen in der Pathogenität von Fusarium oxysporum
2018-2019 Postdoc, Nachwuchsgruppe Biobricks Mikrobieller Naturstoffsynthesen (Dr. Vito Valiante), Leibniz-HKI, Jena
2017 Postdoc, Abt. Molekulare Biotechnologie der Pilze (Prof. Bettina Tudzynski), Westfälische Wilhelms-Universität Münster (WWU Münster)
2014-2017 Promotion mit Auszeichnung (summa cum laude), Abt. Molekulare Biotechnologie der Pilze (Prof. Bettina Tudzynski), WWU Münster
  Dissertation ‘Exploring the biosynthesis and regulation of novel secondary metabolite gene clusters in Fusarium fujikuroi via a combination of bioinformatic, molecular and chemical approaches’
2011-2014 Master of Science in Biotechnologie, WWU Münster
2012 Internationaler Forschungsaufenthalt, Universität Bristol, Vereinigtes Königreich
2008-2011 Bachelor of Science in Biowissenschaften, WWU Münster
2008 Abitur, Heinrich-Heine-Gymnasium Oberhausen

Themenfelder

Publikationen

Bissell AU, Rautschek J, Hoefgen S, Raguž L, Mattern DJ, Saeed N, Janevska S, Jojić K, Huang Y, Kufs JE, Herboeck B, Guo H, Hillmann F, Beemelmanns C, Valiante V (2022) Biosynthesis of the sphingolipid inhibitors sphingofungins in filamentous fungi requires aminomalonate as a metabolic precursor. ACS Chem Biol 17(2), 386-394.
Janevska S, Ferling I, Jojić K, Rautschek J, Hoefgen S, Proctor RH, Hillmann F, Valiante V (2020) Self-protection against the sphingolipid biosynthesis inhibitor fumonisin B1 is conferred by a FUM cluster-encoded ceramide synthase. mBio 11(3), e00455-20.
Manfiolli AO, Siqueira FS, Dos Reis TF, Van Dijck P, Schrevens S, Hoefgen S, Föge M, Straßburger M, de Assis LJ, Heinekamp T, Rocha MC, Janevska S, Brakhage AA, Malavazi I, Goldman GH, Valiante V (2019) Mitogen-activated protein kinase cross-talk interaction modulates the production of melanins in Aspergillus fumigatus. mBio 10(2), e00215-19.
Janevska S, Baumann L, Sieber CMK, Münsterkötter M, Ulrich J, Kämper J, Güldener U, Tudzynski B (2018) Elucidation of the two H3K36me3 histone methyltransferases Set2 and Ash1 in Fusarium fujikuroi unravels their different chromosomal targets and a major impact of Ash1 on genome stability. Genetics 208(1), 153-171.
Janevska S, Güldener U, Sulyok M, Tudzynski B, Studt L (2018) Set1 and Kdm5 are antagonists for H3K4 methylation and regulators of the major conidiation-specific transcription factor gene ABA1 in Fusarium fujikuroi. Environ Microbiol [Epub ahead of print]
Janevska S, Tudzynski B (2018) Secondary metabolism in Fusarium fujikuroi: strategies to unravel the function of biosynthetic pathways. Appl Microbiol Biotechnol 102(2), 615-630.
Niehaus EM, Rindermann L, Janevska S, Münsterkötter M, Güldener U, Tudzynski B (2018) Analysis of the global regulator Lae1 uncovers a connection between Lae1 and the histone acetyltransferase HAT1 in Fusarium fujikuroi. Appl Microbiol Biotechnol 102(1), 279-295.
Arndt B, Janevska S, Schmid R, Hübner F, Tudzynski B, Humpf HU (2017) A Fungal N-Dimethylallyltryptophan Metabolite from Fusarium fujikuroi. Chembiochem 18(10), 899-904.
Janevska S, Arndt B, Baumann L, Apken LH, Mauriz Marques LM, Humpf HU, Tudzynski B (2017) Establishment of the Inducible Tet-On System for the Activation of the Silent Trichosetin Gene Cluster in Fusarium fujikuroi. Toxins (Basel) 9(4),
Niehaus EM, Kim HK, Münsterkötter M, Janevska S, Arndt B, Kalinina SA, Houterman PM, Ahn IP, Alberti I, Tonti S, Kim DW, Sieber CMK, Humpf HU, Yun SH, Güldener U, Tudzynski B (2017) Comparative genomics of geographically distant Fusarium fujikuroi isolates revealed two distinct pathotypes correlating with secondary metabolite profiles. PLOS Pathog 13(10), e1006670.